159 related articles for article (PubMed ID: 16259717)
1. The peroxisome proliferator-activated receptor alpha activator, Wy14,643, is anti-inflammatory in vivo.
Colville-Nash P; Willis D; Papworth J; Freemantle C; Lam C; Andrews G; Willoughby D
Inflammopharmacology; 2005; 12(5-6):493-504. PubMed ID: 16259717
[TBL] [Abstract][Full Text] [Related]
2. Intravenous anesthetic propofol suppresses prostaglandin E2 and cysteinyl leukotriene production and reduces edema formation in arachidonic acid-induced ear inflammation.
Inada T; Hirota K; Shingu K
J Immunotoxicol; 2015; 12(3):261-5. PubMed ID: 25046027
[TBL] [Abstract][Full Text] [Related]
3. ER-34122, a novel dual 5-lipoxygenase/cyclooxygenase inhibitor with potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model.
Horizoe T; Nagakura N; Chiba K; Shirota H; Shinoda M; Kobayashi N; Numata H; Okamoto Y; Kobayashi S
Inflamm Res; 1998 Oct; 47(10):375-83. PubMed ID: 9831321
[TBL] [Abstract][Full Text] [Related]
4. Absence of modulation of monokine production via endogenous cyclooxygenase or 5-lipoxygenase metabolites: MK-886 (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2- dimethylpropanoic acid), indomethacin, or arachidonate fail to alter immunoreactive interleukin-1 beta, or TNF-alpha production by human monocytes in vitro.
Hoffman T; Lee YL; Lizzio EF; Tripathi AK; Jessop JJ; Taplits M; Abrahamsen TG; Carter CS; Puri J
Clin Immunol Immunopathol; 1991 Mar; 58(3):399-408. PubMed ID: 1900463
[TBL] [Abstract][Full Text] [Related]
5. CP-66,248, a new anti-inflammatory agent, is a potent inhibitor of leukotriene B4 and prostanoid synthesis in human polymorphonuclear leucocytes in vitro.
Moilanen E; Alanko J; Asmawi MZ; Vapaatalo H
Eicosanoids; 1988; 1(1):35-9. PubMed ID: 2856170
[TBL] [Abstract][Full Text] [Related]
6. Enzymes involved in the biosynthesis of leukotriene B4 and prostaglandin E2 are active in sebaceous glands.
Alestas T; Ganceviciene R; Fimmel S; Müller-Decker K; Zouboulis CC
J Mol Med (Berl); 2006 Jan; 84(1):75-87. PubMed ID: 16388388
[TBL] [Abstract][Full Text] [Related]
7. Phorbol ester-induced dermal inflammation in mice: evaluation of inhibitors of 5-lipoxygenase and antagonists of leukotriene B4 receptor.
Rao TS; Yu SS; Djuric SW; Isakson PC
J Lipid Mediat Cell Signal; 1994 Sep; 10(3):213-28. PubMed ID: 7812673
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of black tea theaflavin derivatives on 12-O-tetradecanoylphorbol-13-acetate-induced inflammation and arachidonic acid metabolism in mouse ears.
Huang MT; Liu Y; Ramji D; Lo CY; Ghai G; Dushenkov S; Ho CT
Mol Nutr Food Res; 2006 Feb; 50(2):115-22. PubMed ID: 16404705
[TBL] [Abstract][Full Text] [Related]
9. Involvement of LTB4 in zymosan-induced joint nociception in mice: participation of neutrophils and PGE2.
Guerrero AT; Verri WA; Cunha TM; Silva TA; Schivo IR; Dal-Secco D; Canetti C; Rocha FA; Parada CA; Cunha FQ; Ferreira SH
J Leukoc Biol; 2008 Jan; 83(1):122-30. PubMed ID: 17913976
[TBL] [Abstract][Full Text] [Related]
10. An anti-inflammatory ditriazine inhibiting leukocyte functions and expression of inducible nitric oxide synthase and cyclo-oxygenase-2.
Rioja I; Ubeda A; Terencio MC; Guillén I; Riguera R; Quintela JM; Peinador C; González LM; Alcaraz MJ
Eur J Pharmacol; 2000 May; 397(1):207-17. PubMed ID: 10844115
[TBL] [Abstract][Full Text] [Related]
11. Leukotriene B4 creates a favorable microenvironment for murine melanoma growth.
Bachi AL; Kim FJ; Nonogaki S; Carneiro CR; Lopes JD; Jasiulionis MG; Correa M
Mol Cancer Res; 2009 Sep; 7(9):1417-24. PubMed ID: 19737966
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the antiinflammatory activity of a dual cyclooxygenase-2 selective/5-lipoxygenase inhibitor, RWJ 63556, in a canine model of inflammation.
Kirchner T; Argentieri DC; Barbone AG; Singer M; Steber M; Ansell J; Beers SA; Wachter MP; Wu W; Malloy E; Stewart A; Ritchie DM
J Pharmacol Exp Ther; 1997 Aug; 282(2):1094-101. PubMed ID: 9262379
[TBL] [Abstract][Full Text] [Related]
13. Leukotriene B4 is a physiologically relevant endogenous peroxisome proliferator-activated receptor-alpha agonist.
Narala VR; Adapala RK; Suresh MV; Brock TG; Peters-Golden M; Reddy RC
J Biol Chem; 2010 Jul; 285(29):22067-74. PubMed ID: 20400503
[TBL] [Abstract][Full Text] [Related]
14. Involvement of leukotriene B(4) in substance P-induced itch-associated response in mice.
Andoh T; Katsube N; Maruyama M; Kuraishi Y
J Invest Dermatol; 2001 Dec; 117(6):1621-6. PubMed ID: 11886531
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of indomethacin-induced anti-inflammatory response by pioglitazone in carrageenan-induced acute inflammation in rats: Role of PPARγ receptors.
Houshmand G; Mansouri MT; Naghizadeh B; Hemmati AA; Hashemitabar M
Int Immunopharmacol; 2016 Sep; 38():434-42. PubMed ID: 27376854
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of inducible nitric oxide synthase by peroxisome proliferator-activated receptor agonists: correlation with induction of heme oxygenase 1.
Colville-Nash PR; Qureshi SS; Willis D; Willoughby DA
J Immunol; 1998 Jul; 161(2):978-84. PubMed ID: 9670978
[TBL] [Abstract][Full Text] [Related]
17. In vitro effects of E3040, a dual inhibitor of 5-lipoxygenase and thromboxane A(2) synthetase, on eicosanoid production.
Oketani K; Nagakura N; Harada K; Inoue T
Eur J Pharmacol; 2001 Jun; 422(1-3):209-16. PubMed ID: 11430933
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory properties of docosahexaenoic and eicosapentaenoic acids in phorbol-ester-induced mouse ear inflammation.
Raederstorff D; Pantze M; Bachmann H; Moser U
Int Arch Allergy Immunol; 1996 Nov; 111(3):284-90. PubMed ID: 8917124
[TBL] [Abstract][Full Text] [Related]
19. The influence of acetylshikonin, a natural naphthoquinone, on the production of leukotriene B4 and thromboxane A2 in rat neutrophils.
Hsu MF; Chang LC; Huang LJ; Kuo SC; Lee HY; Lu MC; Wang JP
Eur J Pharmacol; 2009 Apr; 607(1-3):234-43. PubMed ID: 19232341
[TBL] [Abstract][Full Text] [Related]
20. L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2 - dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor.
Gillard J; Ford-Hutchinson AW; Chan C; Charleson S; Denis D; Foster A; Fortin R; Leger S; McFarlane CS; Morton H
Can J Physiol Pharmacol; 1989 May; 67(5):456-64. PubMed ID: 2548691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
